# Cyberloq Technologies, Inc.: financial statements, quarterly

CLOQ · OTC · CIK 1437517 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cloq.md) · [Financials](/companies/cloq/financials.md) · [Filings](/companies/cloq/filings.md) · [Insiders](/companies/cloq/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cloq/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [0.0 d](/filings/0001493152-24-045616.md) | [15.0 d](/filings/0001641172-25-001165.md) | [15.0](/filings/0001641172-25-009976.md) | [0.0 d](/filings/0001641172-25-023402.md) | [0.0 d](/filings/0001493152-25-023235.md) | [0.0 d](/filings/0001493152-26-010037.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $k | [5.9](/filings/0001493152-24-045616.md) | [4.7 d](/filings/0001641172-25-001165.md) | [5.7](/filings/0001641172-25-009976.md) | [12.1](/filings/0001641172-25-023402.md) | [15.7](/filings/0001493152-25-023235.md) | [18.5 d](/filings/0001493152-26-010037.md) | [30.1](/filings/0001493152-26-023656.md) | [27.2](/filings/0001641172-25-023402.md) | [16.2](/filings/0001493152-25-023235.md) | [32.4 d](/filings/0001493152-26-010037.md) | [27.8](/filings/0001493152-26-023656.md) | not reported |
| Operating income | $k | [(81.4)](/filings/0001493152-24-045616.md) | [(95.6) d](/filings/0001641172-25-001165.md) | [(196)](/filings/0001641172-25-009976.md) | [(162)](/filings/0001641172-25-023402.md) | [(144)](/filings/0001493152-25-023235.md) | [(251) d](/filings/0001493152-26-010037.md) | [(267)](/filings/0001493152-26-023656.md) | [(163)](/filings/0001493152-26-039220.md) | [(151)](/filings/0001493152-25-023235.md) | [(190) d](/filings/0001493152-26-010037.md) | [(185)](/filings/0001493152-26-023656.md) | [(115)](/filings/0001493152-26-039220.md) |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [79.8](/filings/0001493152-26-039220.md) | not reported | not reported | not reported | [109](/filings/0001493152-26-039220.md) |
| Net income | $k | [(283)](/filings/0001493152-24-045616.md) | [(374)](/filings/0001493152-24-045616.md) | [(247)](/filings/0001493152-25-023235.md) | [(218)](/filings/0001493152-25-023235.md) | [(216)](/filings/0001493152-25-023235.md) | [(309)](/filings/0001493152-25-023235.md) | [(341)](/filings/0001493152-26-039220.md) | [(243)](/filings/0001493152-26-039220.md) | [(246)](/filings/0001493152-26-039220.md) | [(298)](/filings/0001493152-26-039220.md) | [(234)](/filings/0001493152-26-039220.md) | [(225)](/filings/0001493152-26-039220.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001493152-24-045616.md) | not reported | [0.00](/filings/0001641172-25-009976.md) | [0.00](/filings/0001641172-25-023402.md) | [0.00](/filings/0001493152-25-023235.md) | not reported | [0.00](/filings/0001493152-26-023656.md) | [0.00](/filings/0001493152-26-039220.md) | [0.00](/filings/0001493152-25-023235.md) | not reported | [0.00](/filings/0001493152-26-023656.md) | [0.00](/filings/0001493152-26-039220.md) |
| Basic EPS | $ per share | [0.00](/filings/0001493152-24-045616.md) | not reported | [0.00](/filings/0001641172-25-009976.md) | [0.00](/filings/0001641172-25-023402.md) | [0.00](/filings/0001493152-25-023235.md) | not reported | [0.00](/filings/0001493152-26-023656.md) | [0.00](/filings/0001493152-26-039220.md) | [0.00](/filings/0001493152-25-023235.md) | not reported | [0.00](/filings/0001493152-26-023656.md) | [0.00](/filings/0001493152-26-039220.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Gross profit: not reported
- Research and development: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $k | [45.8](/filings/0001493152-23-039457.md) | [307](/filings/0001641172-25-001165.md) | [127](/filings/0001493152-24-019806.md) | [142](/filings/0001493152-24-033230.md) | [190](/filings/0001493152-24-045616.md) | [283](/filings/0001493152-26-010037.md) | [58.2](/filings/0001641172-25-009976.md) | [86.5](/filings/0001641172-25-023402.md) | [103](/filings/0001493152-25-023235.md) | [262](/filings/0001493152-26-039220.md) | [10.1](/filings/0001493152-26-023656.md) | [50.0](/filings/0001493152-26-039220.md) |
| Current assets | $k | [67.2](/filings/0001493152-23-039457.md) | [362](/filings/0001641172-25-001165.md) | [221](/filings/0001493152-24-019806.md) | [198](/filings/0001493152-24-033230.md) | [236](/filings/0001493152-24-045616.md) | [290](/filings/0001493152-26-010037.md) | [93.7](/filings/0001641172-25-009976.md) | [133](/filings/0001641172-25-023402.md) | [146](/filings/0001493152-25-023235.md) | [297](/filings/0001493152-26-039220.md) | [43.9](/filings/0001493152-26-023656.md) | [95.3](/filings/0001493152-26-039220.md) |
| Total assets | $k | [905](/filings/0001493152-23-039457.md) | [1,459](/filings/0001641172-25-001165.md) | [1,410](/filings/0001493152-24-019806.md) | [1,503](/filings/0001493152-24-033230.md) | [1,670](/filings/0001493152-24-045616.md) | [1,843](/filings/0001493152-26-010037.md) | [1,802](/filings/0001641172-25-009976.md) | [2,005](/filings/0001641172-25-023402.md) | [2,174](/filings/0001493152-25-023235.md) | [2,525](/filings/0001493152-26-039220.md) | [2,421](/filings/0001493152-26-023656.md) | [2,611](/filings/0001493152-26-039220.md) |
| Current liabilities | $k | [659](/filings/0001493152-23-039457.md) | [991](/filings/0001641172-25-001165.md) | [1,291](/filings/0001493152-24-019806.md) | [2,096](/filings/0001493152-24-033230.md) | [2,465](/filings/0001493152-24-045616.md) | [2,801](/filings/0001493152-26-010037.md) | [2,895](/filings/0001641172-25-009976.md) | [3,324](/filings/0001641172-25-023402.md) | [3,726](/filings/0001493152-25-023235.md) | [4,160](/filings/0001493152-26-039220.md) | [4,205](/filings/0001493152-26-023656.md) | [4,605](/filings/0001493152-26-039220.md) |
| Total liabilities | $k | [690](/filings/0001493152-23-039457.md) | [1,021](/filings/0001641172-25-001165.md) | [1,321](/filings/0001493152-24-019806.md) | [2,127](/filings/0001493152-24-033230.md) | [2,495](/filings/0001493152-24-045616.md) | [2,831](/filings/0001493152-26-010037.md) | [2,925](/filings/0001641172-25-009976.md) | [3,354](/filings/0001641172-25-023402.md) | [3,756](/filings/0001493152-25-023235.md) | [4,191](/filings/0001493152-26-039220.md) | [4,236](/filings/0001493152-26-023656.md) | [4,635](/filings/0001493152-26-039220.md) |
| Long-term debt | $k | not reported | not reported | not reported | not reported | not reported | not reported | [32.5](/filings/0001641172-25-009976.md) | [32.5](/filings/0001641172-25-023402.md) | [32.5](/filings/0001493152-25-023235.md) | not reported | [32.5](/filings/0001493152-26-023656.md) | [32.5](/filings/0001493152-26-039220.md) |
| Short-term borrowings | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $k | [216](/filings/0001493152-24-045616.md) | [437](/filings/0001493152-26-010037.md) | [369](/filings/0001493152-25-023235.md) | [(624)](/filings/0001493152-25-023235.md) | [(825)](/filings/0001493152-25-023235.md) | [(989)](/filings/0001493152-26-039220.md) | [(1,124)](/filings/0001493152-26-039220.md) | [(1,582)](/filings/0001493152-26-039220.md) | [(1,582)](/filings/0001493152-26-039220.md) | [(1,666)](/filings/0001493152-26-039220.md) | [(1,815)](/filings/0001493152-26-039220.md) | [(2,024)](/filings/0001493152-26-039220.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(14.3) d](/filings/0001493152-24-045616.md) | [(78.2) d](/filings/0001641172-25-001165.md) | [(198)](/filings/0001641172-25-009976.md) | [(127) d](/filings/0001641172-25-023402.md) | [(138) d](/filings/0001493152-25-023235.md) | [(253) d](/filings/0001493152-26-010037.md) | [(276)](/filings/0001493152-26-023656.md) | [(128) d](/filings/0001493152-26-039220.md) | [(159) d](/filings/0001493152-25-023235.md) | [(213) d](/filings/0001493152-26-010037.md) | [(232)](/filings/0001493152-26-023656.md) | [(57.0) d](/filings/0001493152-26-039220.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [105](/filings/0001493152-23-039457.md) | [120](/filings/0001493152-24-019806.md) | [121](/filings/0001493152-24-033230.md) | [121](/filings/0001493152-24-045616.md) | [125](/filings/0001641172-25-009976.md) | [126](/filings/0001641172-25-023402.md) | [126](/filings/0001493152-25-023235.md) | [132](/filings/0001493152-26-023656.md) | [132](/filings/0001493152-26-039220.md) | [133](/filings/0001493152-25-023235.md) | [141](/filings/0001493152-26-023656.md) | [141](/filings/0001493152-26-039220.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 146,146,254 at 2026-08-19, from the cover of the [10-Q filed 2026-08-19](/filings/0001493152-26-039220.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.